HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher R McCurdy Selected Research

Ligands

6/2022Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain.
1/2022In vitro and in vivo pharmacology of kratom.
11/2021Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells.
3/2021In vitro and in vivo sigma 1 receptor imaging studies in different disease states.
11/2020Bioanalytical method development and pharmacokinetics of MCI-92, a sigma-1 receptor ligand.
1/2020Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo.
1/2019Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivatives.
1/2017A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
8/2015Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.
11/2014Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher R McCurdy Research Topics

Disease

21Pain (Aches)
06/2022 - 12/2005
12Neoplasms (Cancer)
09/2021 - 01/2011
11Opioid-Related Disorders (Opiate Addiction)
01/2022 - 12/2011
6Neuralgia (Stump Neuralgia)
06/2022 - 01/2017
6Hyperthermia
02/2014 - 10/2011
5Hyperalgesia
06/2022 - 11/2014
5Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2022 - 02/2008
4Chronic Pain
06/2022 - 06/2008
4Substance-Related Disorders (Drug Abuse)
01/2020 - 02/2011
3Neuroblastoma
01/2019 - 08/2015
2COVID-19
11/2021 - 01/2020
2Parkinson Disease (Parkinson's Disease)
09/2021 - 04/2014
2Nervous System Diseases (Neurological Disorders)
09/2021 - 01/2011
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2019
2Fatigue
01/2020 - 01/2019
2Neuroinflammatory Diseases
01/2017 - 04/2014
1Virus Diseases (Viral Diseases)
11/2021
1Acquired Immunodeficiency Syndrome (AIDS)
10/2021
1Hypercapnia
09/2021
1Opiate Overdose
09/2021
1Respiratory Insufficiency (Respiratory Failure)
09/2021
1Inflammation (Inflammations)
01/2021
1Rett Syndrome (Rett's Disorder)
01/2021
1Pelvic Pain
01/2021
1Fragile X Syndrome (Martin Bell Syndrome)
01/2021
1Neurodevelopmental Disorders
01/2021
1Mental Disorders (Mental Disorder)
01/2020
1Leukemia
12/2019
1Thrombocytopenia (Thrombopenia)
12/2019
1Drug-Related Side Effects and Adverse Reactions
12/2019
1Obesity
10/2018
1Cancer Pain
08/2017
1Retinal Degeneration
08/2017
1Neuroma
01/2017
1Catalepsy
11/2015
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2015
1Fever (Fevers)
11/2015
1Gliosis
04/2014
1Cognitive Dysfunction
06/2013
1Stroke (Strokes)
12/2012
1Anhedonia
10/2012

Drug/Important Bio-Agent (IBA)

19Opioid Analgesics (Opioids)IBA
01/2022 - 02/2008
10LigandsIBA
06/2022 - 11/2014
9sigma-2 receptorIBA
06/2022 - 08/2015
9Pharmaceutical PreparationsIBA
08/2021 - 12/2005
7sigma Receptors (sigma Receptor)IBA
06/2022 - 01/2011
7Methamphetamine (Desoxyn)FDA LinkGeneric
01/2017 - 09/2012
6mitragynineIBA
01/2022 - 02/2008
5Analgesics (Analgesic Drugs)IBA
06/2022 - 07/2015
5Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2011
5Sigma-1 ReceptorIBA
01/2021 - 01/2017
3Dopamine (Intropin)FDA LinkGeneric
06/2013 - 02/2011
2Gabapentin (Neurontin)FDA LinkGeneric
06/2022 - 01/2019
2Morphine (MS Contin)FDA LinkGeneric
10/2021 - 01/2019
2Opioid Receptors (Opioid Receptor)IBA
11/2020 - 10/2012
2Formaldehyde (Formol)FDA Link
01/2020 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2017
2Antineoplastic Agents (Antineoplastics)IBA
12/2019 - 02/2016
2BromidesIBA
01/2019 - 02/2016
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
10/2018 - 09/2014
2Cocaine (Cocaine HCl)IBA
01/2017 - 03/2012
2phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA
11/2014 - 06/2012
2salvinorin AIBA
10/2012 - 02/2008
23- (4- (4- cyclohexylpiperazin- 1- yl)butyl)benzo(d)thiazole- 2(3H)- thioneIBA
03/2012 - 10/2011
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2022
1OpiumIBA
01/2022
1Stavudine (Zerit)FDA LinkGeneric
10/2021
1Antiviral Agents (Antivirals)IBA
10/2021
1FlavonoidsIBA
09/2021
1Fentanyl (Sublimaze)FDA LinkGeneric
09/2021
1Indole AlkaloidsIBA
02/2021
1N- dimethyl- 2,2- diphenyl- 3- furanmethanamine hydrochloride tetrahydro-NIBA
01/2021
1Therapeutic UsesIBA
11/2020
1TeaIBA
11/2020
1DT2216IBA
12/2019
1snake venom protein C activatorIBA
12/2019
1navitoclaxIBA
12/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1Opiate AlkaloidsIBA
01/2019
1AlkaloidsIBA
01/2019
1RacivirIBA
01/2017
1Dihydrotachysterol (AT 10)IBA
11/2015
1CalciumIBA
08/2015
1KetorolacIBA
07/2015
1Indomethacin (Indometacin)FDA LinkGeneric
07/2015
1NeuropeptidesIBA
11/2014
1NF-kappa B (NF-kB)IBA
10/2014
1Messenger RNA (mRNA)IBA
04/2014
1CytokinesIBA
04/2014
1Oncostatin M Receptors (Oncostatin M Receptor)IBA
04/2014
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2013
1Sucrose (Saccharose)IBA
10/2012
1SolutionsIBA
10/2012

Therapy/Procedure

8Therapeutics
06/2022 - 08/2015
2Drug Therapy (Chemotherapy)
01/2019 - 12/2011
1Highly Active Antiretroviral Therapy (HAART)
10/2021
1Pain Management
01/2021
1Injections
01/2021
1Traditional Medicine (Folk Remedies)
11/2015